In vitro and in vivo effects of Galectin‐3 inhibitor TD139 on inflammation and ERK/JNK/p38 pathway i...
In vitro and in vivo effects of Galectin‐3 inhibitor TD139 on inflammation and ERK/JNK/p38 pathway in gestational diabetes mellitus
About this item
Full title
Author / Creator
Xia, Ji , Wang, Yan and Qi, Bang‐Ruo
Publisher
BP, Asia: Wiley Publishing Asia Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BP, Asia: Wiley Publishing Asia Pty Ltd
Subjects
More information
Scope and Contents
Contents
This study aims to investigate the effects of the Galectin‐3 (Gal‐3) inhibitor TD139 on inflammation and the extracellular signal‐regulated kinase (ERK)/c‐Jun N‐terminal kinase (JNK)/p38 pathway in gestational diabetes mellitus (GDM). Human placental tissues were treated with TD139 and TNF‐α, assessing Gal‐3, ERK/JNK/p38 activation, and inflammator...
Alternative Titles
Full title
In vitro and in vivo effects of Galectin‐3 inhibitor TD139 on inflammation and ERK/JNK/p38 pathway in gestational diabetes mellitus
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_88cb4030263f4b4e9532d24708230ad7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_88cb4030263f4b4e9532d24708230ad7
Other Identifiers
ISSN
1607-551X,2410-8650
E-ISSN
2410-8650
DOI
10.1002/kjm2.12890
